imexpharm honoured with vietnam pharmaceutical star award

Imexpharm honoured with Vietnam Pharmaceutical Star award

Imexpharm Pharmaceutical JSC proudly received the “Vietnam Pharmaceutical Star” award on May 17.
imexpharm welcomes shareholders analysts and potential investors at agm

Imexpharm welcomes shareholders, analysts and potential investors at AGM

Imexpharm Corporation (Imexpharm), a pioneering leader in Vietnam’s pharmaceutical industry, held its AGM at the Hilton Saigon Hotel on April 26.
outlook for pharmaceutical stocks in 2024

Outlook for pharmaceutical stocks in 2024

At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.
imexpharm set growth record in 2023

Imexpharm set growth record in 2023

Imexpharm Corporation (Imexpharm or IMP.VN), a pioneer in Vietnam’s pharmaceutical industry, announced its business results on March 27, for the fiscal year ending December 31, 2023.
imexpharm joins vietnams campaign to plant one billion trees

Imexpharm joins Vietnam's campaign to plant one billion trees

Imexpharm Pharmaceutical JSC (IMP) teamed up with Nha Trang People's Committee to plant 500 trees along Ring Road 2 on March 18.
imexpharm forges partnership with genuone sciences

Imexpharm forges partnership with Genuone Sciences

On February 23, Imexpharm JSC (IMP) officially announced the signing of a strategic cooperation agreement with Genuone Sciences Inc., one of the leading pharmaceutical companies from South Korea.
imexpharm opens new representative office in ho chi minh city

Imexpharm opens new representative office in Ho Chi Minh City

Imexpharm has opened a new office to grasp fresh opportunities for growth after a period of in-depth investment in modern production technologies.
domestic pharmaceutical products anticipate 2024 boost

Domestic pharmaceutical products anticipate 2024 boost

2023 witnessed many fluctuations in the economy, with various industrial fields witnessing negative growth, but the pharmaceutical industry remains growing thanks to the breakthroughs of leading pharmaceutical companies.
imexpharm clinches top honours in corporate annual reporting

Imexpharm clinches top honours in corporate annual reporting

Imexpharm, outstripping its 2023 financial targets, underscores its ascent with top honours in corporate governance, affirming its stature in Vietnam's pharmaceutical sector.
sk investment vina iii to hold 65 per cent of imexpharm

SK Investment Vina III to hold 65 per cent of Imexpharm

SK Investment Vina III Pte. Ltd (SK Vina III), a subsidiary of South Korea’s third-largest conglomerate SK Group, aims to hold a 65 per cent stake in Imexpharm Pharmaceutical JSC (IMP).
imexpharm honoured as top 5 company with best working environment in vietnam

Imexpharm honoured as top 5 company with best working environment in Vietnam

Imexpharm Pharmaceutical JSC has been named in the top 5 companies with the best working environment in Vietnam for pharmaceuticals, medical devices, and healthcare companies in the medium-sized enterprise category.
imexpharm raises its status with eu gmp standard factories

Imexpharm raises its status with EU-GMP-standard factories

Operating the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become a leading pharmaceutical enterprise. These advantages are also shown through the company's impressive business results.
imexpharm making inroads in achieving sustainable efficiency

Imexpharm making inroads in achieving sustainable efficiency

After four decades of development, Imexpharm Corporation has reaffirmed its position as a market leader in Vietnam’s pharmaceutical industry by investing in sustainable technology and human resources.
imexpharm corporation reports dropping revenue during social distancing

Imexpharm Corporation reports dropping revenue during social distancing

In August, Imexpharm Corporation recognised a decrease of 12 per cent in revenue and 14 per cent in profit due to social distancing.
sk investment vina raises ownership to 292 per cent in imexpharm

SK Investment Vina raises ownership to 29.2 per cent in Imexpharm

SK Investment Vina III Pte., Ltd. has spent over VND34.5 billion ($1.5 million) to acquire 3.4 million shares of Imexpharm Pharmaceutical JSC to raise its ownership at the firm to 29.22 per cent.